25.40
+0.075(+0.30%)
Currency In USD
Address
235 East 42nd Street
New York City, NY 10017
United States of America
Phone
212 733 2323
Website
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
81000
First IPO Date
June 01, 1972
Name | Title | Pay | Year Born |
Dr. Albert Bourla D.V.M., Ph.D. | Chairman of the Board & Chief Executive Officer | 9.82M | 1962 |
Mr. Douglas M. Lankler | Executive Vice President & Chief Legal Officer | 1.76M | 1966 |
Mr. David M. Denton | Chief Financial Officer & Executive Vice President | 4.55M | 1965 |
Dr. Chris Boshoff FMedSci, M.D., Ph.D. | Chief Scientific Officer and President of Research & Development | 4.71M | 1964 |
Ms. Payal Sahni Becher | Chief People Experience Officer & Executive Vice President | 0 | 1975 |
Ms. Jennifer B. Damico | Senior Vice President, Controller & Principal Accounting Officer | 0 | 1968 |
Ms. Sally M. Susman | Executive Vice President & Chief Corporate Affairs Officer | 0 | 1962 |
Dr. Michael S. Vincent M.D., Ph.D. | Senior Vice President and Chief Scientific Officer of Inflammation & Immunology | 0 | N/A |
Ms. Lidia L. Fonseca | Executive Vice President and Chief Digital & Technology Officer | 0 | 1969 |
Ms. Francesca M. DeMartino | Chief Investor Relations Officer | 0 | N/A |
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.